Brief: AtriCure Q3 Adjusted EPS USD -0.01 Vs. IBES Estimate USD -0.12
Oct 29 (Reuters) - AtriCure Q3 gross profit USD 101.3 million. Q3 adjusted EBITDA USD 17.8 million vs. IBES estimate USD 11.6 million Q3 gross margin 75.5% Q3 operating income USD 200 thousand Q3 revenue USD 134.3 million vs. IBES estimate USD 131.3 million outlook FY revenue USD 532-534 million outlook FY adjusted EBITDA USD 55-57 million outlook FY adjusted EPS USD -0.26 to -0.23
Recent news on AtriCure
See all newsBrief: Inspire Medical Systems, Inc. Announces Appointment Of Seasoned Medical Device Executive Michael H. Carrel To Its Board Of Directors
AtriCure Inc reports results for the quarter ended June 30 - Earnings Summary
AtriCure Q2 revenue beats estimates
Brief: AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0
AtriCure Q1 revenue beats estimates, co raises 2026 outlook